Company: ATRA
Filing Date: 2025-01-16
Form Type: 8-K
Source: 0000950170-25-006191
Chunk: 0

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-01-16
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

In connection with the press release described in Item 8.01 below, on January 16, 2025, Atara Biotherapeutics, Inc. (the “ Company”) announced the Company’s cash, cash equivalents and short-term investments as of December 31, 2024. The preliminary estimate is based on currently available information and does not present all necessary information for a complete understanding of the Company’s financial condition as of December 31, 2024 or the Company’s results of operations for the fourth quarter or year ended December 31, 2024.

Item 8.01 Other Events.